The agreements with the US Federal Trade Commission and the UK Competition and Markets Authority are the last regulatory hurdles in the way of Stryker’s planned $4bn acquisition of Wright Medical.
Stryker Corporation will divest its STAR total ankle replacement products and finger joint replacement products as part of an agreement with the US Federal Trade Commission (FTC) that clears the way for Stryker to complete its planned acquisition of Wright Medical Group N.V., the companies announced on 4 November.
Following the regulatory approvals, Stryker was able to close the acquisition of Wright on 11 November. (Also see "Stryker...
When a large medtech company sets up a venture fund, it typically invests in technologies that are adjacent to its pre-existing portfolio. Intuitive Surgical’s approach is different.
Spain has one of the highest incarceration rates in Europe, with 160 individuals imprisoned per 100,000 residents. In 2020, 43,494 people were incarcerated in facilities not managed by regional health authorities — essentially all regions except Catalonia, the Basque Country, and Navarra.
Biopharmaceutical giant AstraZeneca has partnered with start-up “unicorn” Owkin to develop an AI-powered tool to prescreen for gBRCA mutations on the basis of morphological features in digitized pathology slides. Built on extensive, high-quality data sourced from the France-based PortrAIt consortium, the AI will help to prioritize patients for further testing, streamlining the diagnostic process, Owkin says.
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
